Industry losses from Nanmadol revised to US$1bn: Perils

March 20 2023 by

Loss data specialist Perils has estimated the third industry loss for Nanmadol (Typhoon No. 14) at ¥129.6 billion (US$988 million) as against ¥119.7 billion estimated in December 2022, a statement fro...

To continue reading the full article and get full access to the InsuranceAsia News platform, please enquire about a subscription.

Your company may already have a corporate license in place.

Already a Subscriber? Please Login

MORE FROM: Catastrophe
Partner Content